## **Core Concept**
Haemophilus influenzae is a Gram-negative coccobacillus that can cause invasive infections, including meningitis, particularly in children. The management of such infections is complicated by the emergence of antibiotic-resistant strains, including those producing beta-lactamase and resistant to chloramphenicol.

## **Why the Correct Answer is Right**
The correct answer, **Ceftriaxone**, is a third-generation cephalosporin with potent activity against Gram-negative bacteria, including beta-lactamase-producing strains of Haemophilus influenzae. Ceftriaxone can cross the blood-brain barrier, achieving therapeutic levels in the cerebrospinal fluid (CSF), making it suitable for treating bacterial meningitis. Its effectiveness against beta-lactamase-producing H. influenzae and its ability to be administered intravenously once daily make it a preferred choice in this scenario.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Ampicillin is not suitable because the strain is beta-lactamase producing, which would render ampicillin ineffective.
- **Option B:** Chloramphenicol is resistant in this strain, making it an inappropriate choice for treatment.
- **Option D:** Ciprofloxacin, a fluoroquinolone, is not typically used as a first-line treatment for bacterial meningitis in children due to potential side effects and the availability of more targeted therapies like ceftriaxone.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the introduction of the Hib (Haemophilus influenzae type b) vaccine has significantly reduced the incidence of invasive H. influenzae infections, including meningitis, in children. However, in cases where H. influenzae meningitis is suspected or confirmed, especially with antibiotic resistance, ceftriaxone is a reliable option due to its broad-spectrum activity and penetration into the CSF.

## **Correct Answer:** . Ceftriaxone